Welcome to our dedicated page for Stryker SEC filings (Ticker: SYK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Stryker Corporation filings document the regulatory record of a New York Stock Exchange-listed medical technology issuer with operations in MedSurg, Neurotechnology and Orthopaedics. Its 8-K reports cover operating results, financial-condition updates, material events, Regulation FD disclosures and exhibits tied to company press releases.
The filing record also describes governance and capital-structure matters, including definitive proxy materials, annual-meeting votes, director elections, auditor ratification, executive-compensation votes, common stock and listed senior unsecured notes. Recent material-event filings include cybersecurity incident disclosures and amendments describing operational and reporting updates connected to Stryker's information technology environment.
Stryker Corporation reported a cybersecurity incident that disrupted its global Microsoft-based information technology environment. After detecting the issue on March 11, 2026, the company activated its cybersecurity response plan, brought in external advisors and experts, and believes the incident is currently contained with no indication of ransomware or malware.
The disruption is limiting access to certain information systems and business applications that support Stryker’s operations and corporate functions, and a full restoration timeline is still unknown. Stryker is using business continuity measures to keep serving customers, while an ongoing investigation evaluates the scope, operational effects, and any financial impact. The company has not yet determined whether the incident is reasonably likely to have a material impact.
Stryker Corp Chair and CEO Kevin Lobo received an equity award of 50,332 shares of Common Stock on March 9, 2026 as a grant/award acquisition. The award was earned upon achieving pre-set three-year adjusted diluted net earnings per share goals and sales performance goals, and the earned shares vest on March 21, 2026.
After this award, Lobo directly holds 247,271 shares of Stryker common stock and indirectly holds 721 shares through a 401(k) plan. A one‑share adjustment corrected a previously reported balance related to an earlier option exercise and associated tax withholding.
Stryker Corporation reported that VP and Chief HR Officer M. Kathryn Fink received a grant of 5,220 shares of common stock on March 9, 2026 as a compensation award at $0.00 per share. The award was earned upon achievement of pre-established three-year adjusted diluted net earnings per share and sales performance goals, and the earned shares vest on March 21, 2026. Following this award, Fink directly holds 18,551 shares, with additional indirect holdings of 422 shares through a 401(k) plan and 177 shares through the 2023 Mary Fink Living Trust. The direct holdings include 128 shares acquired under Stryker's Employee Stock Purchase Plan as of December 31, 2025.
Fletcher Robert S reported acquisition or exercise transactions in this Form 4 filing.
STRYKER CORP VP and Chief Legal Officer Robert S. Fletcher reported an equity award of 7,828 shares of Common Stock. The shares were granted at no cash cost as compensation after the achievement of pre-established three-year adjusted diluted net earnings per share and sales performance goals, and will vest on March 21, 2026. Following this award, he directly holds 18,285 common shares, and indirectly holds 162 shares through a 401(k) plan.
STRYKER CORP Group President Viju Menon reported a compensation-related stock award, not an open-market purchase. He acquired 9,320 shares of common stock at no cost as a grant tied to pre-established three-year adjusted diluted net earnings per share and sales performance goals.
The earned shares are scheduled to vest on March 21, 2026. Following this grant, Menon holds 21,831 shares directly and 198 shares indirectly through a 401(k) plan, giving a clearer picture of his overall equity stake in the company.
Stryker Corp President and COO Spencer S. Stiles reported an acquisition of 14,912 shares of Common Stock as a performance-based award. The shares were earned upon meeting pre-established three-year adjusted diluted net earnings per share and sales performance goals and will vest on March 21, 2026.
After this grant, Stiles directly holds 83,894 Stryker shares and has an additional 1,670 shares held indirectly through a 401(k) plan. This filing reflects executive compensation rather than an open-market stock purchase or sale.
Pierce James Andrew reported acquisition or exercise transactions in this Form 4 filing.
Stryker Corp Group President James Andrew Pierce reported an equity award of 14,912 shares of Common Stock. The shares were granted at no cash cost upon achievement of pre-set three-year earnings per share and sales goals and will vest on March 21, 2026.
After this grant, Pierce directly holds 88,246 common shares. He also reports indirect holdings of 712 shares held by "Son GP", 713 shares held by "Son AP", and 1,595 shares held through a 401(k) account as of the same date.
STRYKER CORP director Ronda E. Stryker reported a bona fide gift of 55,600 shares of common stock on behalf of a revocable trust. The trust held 2,231,173 shares after the gift. Additional indirect holdings were 12,857,163 shares in the L. Lee Stryker Trust and 37,600 shares in the 1988 William D. Johnston Trust, plus 560 shares held directly.
Stryker Corp director Ronda E. Stryker reported several indirect trust transactions in company common stock. A revocable trust associated with her made bona fide gifts of 377,900 shares on February 13, 2026 and 222,300 shares on February 17, 2026, both at a stated price of $0.00 per share.
Separately, on February 17, 2026, the L. Lee Stryker Trust, for which she serves as trustee and her children are beneficiaries, distributed 42,000 shares to beneficiaries’ individual trusts. She disclaims beneficial ownership of the L. Lee Stryker Trust holdings except to the extent of her pecuniary interest.
Greenleaf Trust reports beneficial ownership of 16,801,654 shares of Stryker Corp common stock, representing 4.4% of the class as of 12/31/2025. Greenleaf has sole voting power over 181,176 shares and shared voting power over 16,620,478 shares.
The firm has sole dispositive power over 122,825 shares and shared dispositive power over 16,678,829 shares. It holds these securities in a fiduciary capacity for various trust and investment management customers and states they are held in the ordinary course of business, not to change or influence control of Stryker.